Literature DB >> 34272435

The role of leptospiremia and specific immune response in severe leptospirosis.

Umaporn Limothai1,2, Nuttha Lumlertgul1,2,3, Phatadon Sirivongrangson1,2, Win Kulvichit1,2, Sasipha Tachaboon1,2, Janejira Dinhuzen1,2, Watchadaporn Chaisuriyong1,2, Sadudee Peerapornratana1,2,3,4, Chintana Chirathaworn5, Kearkiat Praditpornsilpa3, Somchai Eiam-Ong3, Kriang Tungsanga3, Nattachai Srisawat6,7,8,9,10,11,12.   

Abstract

Leptospirosis can cause a high mortality rate, especially in severe cases. This multicenter cross-sectional study aimed to examine both host and pathogen factors that might contribute to the disease severity. A total of 217 leptospirosis patients were recruited and divided into two groups of non-severe and severe. Severe leptospirosis was defined by a modified sequential organ failure assessment (mSOFA) score of more than two or needed for mechanical ventilation support or had pulmonary hemorrhage or death. We found that leptospiremia, plasma neutrophil gelatinase-associated lipocalin (pNGAL), and interleukin 6 (IL-6) at the first day of enrollment (day 1) and microscopic agglutination test (MAT) titer at 7 days after enrollment (days 7) were significantly higher in the severe group than in the non-severe group. After adjustment for age, gender, and the days of fever, there were statistically significant associations of baseline leptospiremia level (OR 1.70, 95% CI 1.23-2.34, p = 0.001), pNGAL (OR 9.46, 95% CI 4.20-21.33, p < 0.001), and IL-6 (OR 2.82, 95% CI 1.96-4.07, p < 0.001) with the severity. In conclusion, a high leptospiremia, pNGAL, and IL-6 level at baseline were associated with severe leptospirosis.
© 2021. The Author(s).

Entities:  

Year:  2021        PMID: 34272435     DOI: 10.1038/s41598-021-94073-z

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  29 in total

Review 1.  Leptospirosis: aspects of innate immunity, immunopathogenesis and immune evasion from the complement system.

Authors:  T R Fraga; A S Barbosa; L Isaac
Journal:  Scand J Immunol       Date:  2011-05       Impact factor: 3.487

Review 2.  Leptospirosis.

Authors:  Alan J A McBride; Daniel A Athanazio; Mitermayer G Reis; Albert I Ko
Journal:  Curr Opin Infect Dis       Date:  2005-10       Impact factor: 4.915

3.  Cytotoxic activities of Leptospira interrogans hemolysin SphH as a pore-forming protein on mammalian cells.

Authors:  Seoung Hoon Lee; Sangduk Kim; Seung Chul Park; Min Ja Kim
Journal:  Infect Immun       Date:  2002-01       Impact factor: 3.441

4.  Utility of quantitative polymerase chain reaction in leptospirosis diagnosis: association of level of leptospiremia and clinical manifestations in Sri Lanka.

Authors:  Suneth B Agampodi; Michael A Matthias; Angelo C Moreno; Joseph M Vinetz
Journal:  Clin Infect Dis       Date:  2012-02-21       Impact factor: 9.079

Review 5.  Diagnosis and epidemiology of leptospirosis.

Authors:  M Picardeau
Journal:  Med Mal Infect       Date:  2013-01-18       Impact factor: 2.152

Review 6.  Leptospirosis in human: Biomarkers in host immune responses.

Authors:  Chin Vk; Lee Ty; Lim Wf; Wan Shahriman Ywy; Syafinaz An; Zamberi S; Maha A
Journal:  Microbiol Res       Date:  2017-11-28       Impact factor: 5.415

Review 7.  Leptospirosis Pathophysiology: Into the Storm of Cytokines.

Authors:  Julie Cagliero; Sharon Y A M Villanueva; Mariko Matsui
Journal:  Front Cell Infect Microbiol       Date:  2018-06-20       Impact factor: 5.293

8.  A simple score to predict severe leptospirosis.

Authors:  Simon Smith; Brendan J Kennedy; Alexis Dermedgoglou; Suzanne S Poulgrain; Matthew P Paavola; Tarryn L Minto; Michael Luc; Yu-Hsuan Liu; Josh Hanson
Journal:  PLoS Negl Trop Dis       Date:  2019-02-13

9.  Risk factors and predictors of severe leptospirosis in New Caledonia.

Authors:  Sarah Tubiana; Marc Mikulski; Jérôme Becam; Flore Lacassin; Patrick Lefèvre; Ann-Claire Gourinat; Cyrille Goarant; Eric D'Ortenzio
Journal:  PLoS Negl Trop Dis       Date:  2013-01-10

10.  Factors Associated with Severe Leptospirosis, Martinique, 2010-2013.

Authors:  Patrick Hochedez; Rafaelle Theodose; Claude Olive; Pascale Bourhy; Guillaume Hurtrel; Nicolas Vignier; Hossein Mehdaoui; Ruddy Valentino; Roland Martinez; Jean-Marie Delord; Cécile Herrmann; Isabelle Lamaury; Raymond Césaire; Mathieu Picardeau; André Cabié
Journal:  Emerg Infect Dis       Date:  2015-12       Impact factor: 6.883

View more
  1 in total

Review 1.  Going Micro in Leptospirosis Kidney Disease.

Authors:  Wiwat Chancharoenthana; Asada Leelahavanichkul; Marcus J Schultz; Arjen M Dondorp
Journal:  Cells       Date:  2022-02-16       Impact factor: 6.600

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.